{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:33:15Z","timestamp":1788870795757,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.pnpbp.2011.05.003","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T12:30:58Z","timestamp":1305894658000},"page":"1704-1708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy"],"prefix":"10.1016","volume":"35","author":[{"given":"Chie","family":"Usui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Hatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagafumi","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Kamigaichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heii","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2011.05.003_bb0005","series-title":"Scales for the assessment of positive symptoms (SAPS)","author":"Andreasen","year":"1984"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0010","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.amjopharm.2010.08.004","article-title":"Management of hallucinations and psychosis in Parkinson's disease","volume":"8","author":"Eng","year":"2010","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0015","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3109\/00207450903222758","article-title":"Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study","volume":"119","author":"Fernandez","year":"2009","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0020","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.parkreldis.2010.05.004","article-title":"Parkinson's disease psychosis a review article","volume":"16","author":"Friedman","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0025","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archgenpsychiatry.2010.77","article-title":"Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study","volume":"67","author":"Fusar-Poli","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0030","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/mds.10125","article-title":"Monosymptomatic resting tremor and Parkinson's disease: a multitracer positron emission tomographic study","volume":"17","author":"Ghaemi","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0035","article-title":"Clinical Global Impressions (CGI). ECDEU assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0040","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/exnr.2000.7522","article-title":"Dopa-induced blood flow responses in nonhuman primates","volume":"166","author":"Hershey","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01.WCB.0000092831.44769.09","article-title":"Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease","volume":"24","author":"Hilker","year":"2004","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0050","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0055","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1007\/s00259-006-0360-7","article-title":"Regional CBF changes in Parkinson's disease: a correlation with motor dysfunction","volume":"34","author":"Hsu","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1017\/S0317167100027141","article-title":"Treatment of dopaminomimetic psychosis in Parkinson's disease with electroconvulsive therapy","volume":"15","author":"Hurwitz","year":"1988","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0065","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1111\/j.1468-1331.2008.02357.x","article-title":"Effective control of catatonia in Parkinson's disease by electroconvulsive therapy: a case report","volume":"16","author":"Kamigaichi","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0070","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1176\/jnp.15.4.407","article-title":"Electroconvulsive therapy in movement disorders: an update","volume":"15","author":"Kennedy","year":"2003","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0075","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jocn.2005.09.017","article-title":"Parkinsonism-hyperpyrexia syndrome: the role of electroconvulsive therapy","volume":"13","author":"Meagher","year":"2006","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0080","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1212\/01.wnl.0000187116.13370.e0","article-title":"Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations","volume":"65","author":"Oishi","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0085","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/mds.22623","article-title":"Cross-sectional and longitudinal studies of three-dimensional stereotactic surface projection SPECT analysis in Parkinson's disease","volume":"24","author":"Osaki","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/01.yct.0000159325.08303.45","article-title":"Electroconvulsive therapy in drug-induced psychiatric states and neuroleptic malignant syndrome","volume":"21","author":"Ozer","year":"2005","journal-title":"J ECT"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.biopsych.2007.12.010","article-title":"Limbic and frontal cortical degeneration is associated with psychiatric symptoms in PINK1 mutation carriers","volume":"64","author":"Reetz","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.bp.106.023036","article-title":"Changes in regional cerebral blood flow during acute electroconvulsive therapy in patients with depression: positron emission tomographic study","volume":"190","author":"Takano","year":"2007","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0105","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJM199903113401003","article-title":"Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. The Parkinson Study Group","volume":"340","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pnpbp.2011.05.003_bb0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/YCT.0b013e3181c18a3d","article-title":"Marked improvement of psychotic symptoms after electroconvulsive therapy in Parkinson disease","volume":"26","author":"Ueda","year":"2010","journal-title":"J ECT"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611001552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611001552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:41:15Z","timestamp":1759520475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584611001552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0278584611001552"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.05.003","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}